missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ Cysteine Conjugate beta-Lyase/CCBL1 Recombinant Protein Antigen

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Marke:  Novus Biologicals™ NBP1-83316PEP

Artikelnummer. 18297398

  • 291.00 CHF / 0.10 Milliliter
Verfügbar ab: 23-12-2024
Sie sich ein, um den Lagerbestand zu sehen
Entdecken Sie weitere Sonderangebote
Zum Warenkorb hinzufügen
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human CCBL1. The Cysteine Conjugate beta-Lyase/CCBL1 Recombinant Protein Antigen is derived from E. coli. The Cysteine Conjugate beta-Lyase/CCBL1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

This is a blocking peptide for NBP1-83316. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.

Spezifikation

Spezifikation

883
Chromatography
0.5mg/mL
PBS and 1M Urea, pH 7.4.
CCBL1
28kDa
0.1mL
E.Coli
LITDISDFKRKMPDLPGAVDEPYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKVEL
Human
>80%
Store at -20°C. Avoid freeze-thaw cycles.
Blocking/Neutralizing, Control
Unmarkiert
Cysteine Conjugate beta-Lyase/CCBL1
RUO
This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP1-83316. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Sonderangebote

Sonderangebote

Nur für Forschungszwecke